Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review

doi:10.5306/wjco.v11.i6.348

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7866)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

362

WORD

156

HTML

4665

Figures (1-5)

478

Tables (1-2)

272

Sum=5933

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

703

Download

1230

Sum=1933

Jun 24, 2020 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Jun 24, 2020; 11(6): 348-369
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.348

Full Size Figure Download Figure

Figure 2 A top ten discriminative microRNA set for the main acute lymphoblastic leukemia subgroups. The subtypes display a unique discriminating microRNA (except where overlap is shown) that distinguishes each subgroup from each other (modified from Grobbelaar et al[3], with the permission of the author). ALL: Acute lymphoblastic leukemia.

Citation: Szczepanek J. Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review. World J Clin Oncol 2020; 11(6): 348-369
URL: https://www.wjgnet.com/2218-4333/full/v11/i6/348.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i6.348